CHD4 and cancer: This group also reported that increased expression of the CHD4 gene was proportional to cancer treatment resistance by suppressing the expression of the cell cycle inhibitor and anti-proliferative effector, p21, which works together with the DNA-repair gene BRCA to cause an overall decrease in the sensitivity of cells to anticancer treatment.